What regulation governs the requirements for patent applications with nucleotide and/or amino acid sequence disclosures?

The requirements for patent applications with nucleotide and/or amino acid sequence disclosures are governed by 37 CFR 1.831. This is referenced in MPEP 2412.03(c):

37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures.

This regulation sets forth the specific requirements that patent applicants must follow when their applications include nucleotide and/or amino acid sequences, including modified amino acids. It’s important for applicants to be familiar with these requirements to ensure their applications are compliant.

To learn more:

• 37 CFR 1.831
• patent application
• sequence disclosure
• regulations